Specialty Connect: Focus on Gene Therapy
Monday, March 25 | 1:00 pm – 6:30 pm
Networking Reception: 5:30 pm to 6:30 pm
Marriott Marquis San Diego Marina
Note: Registration for Specialty Connect is separate from the AMCP Annual Meeting 2019. Registration Fees: $195 AMCP Members, $295 Non-Members. For additional registration information, click here.
Gene therapy is a fascinating field that has the potential to improve the health of millions of patients. Promising advancements using gene therapy technology and techniques are offering hope for many with rare and serious diseases, including sickle cell disease, hemophilia, cancers, retinal disease, cystic fibrosis, multiple sclerosis, spinal muscular atrophy, and others. Rather than treating these conditions with medications or surgical interventions, gene therapy may allow disorders to be treated by inserting a gene into a patient’s DNA to alter gene expression.
During this program, experts will review the science behind gene therapy and explore payer considerations for supporting patient access to these innovative treatments. Topics for discussion include the science behind gene therapies, the possible benefits and side effects of the products, and current research efforts for gene therapy. In addition, the event will explore managed care and provider strategies for covering and paying for gene therapy.
|1:00 pm - 1:15 pm||Welcome and Introductions|
|1:15 pm - 2:15 pm||Didactic Presentation – Introduction to Gene Therapy: Key Terms, Concepts, and International Perspectives|
|2:15 pm - 3:00 pm||Didactic Presentation - Developments, Research, Pipeline, and Applications of Gene Therapy|
|3:00 pm - 3:20 pm||Break|
|3:20 pm - 4:20 pm||Didactic Presentation - Financial Models to Manage Drug Spend of Gene Therapy|
|4:20 pm - 5:20 pm||Panel Discussion - Perspectives in Gene Therapy Management|
|5:20 pm - 5:30 pm||Closing Remarks/Housekeeping and Audience Q&A|
|5:30 pm - 6:30 pm||Networking Reception|
|6:00 pm - 8:00 pm||Satellite Symposium -ManagedCareHemo.com Presents Hemophilia Clinical Updates and Cost Management Solutions|
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). Pharmacists can earn a maximum of 3.75 contact hours of CPE credit by attending all CPE sessions during Specialty Connect (not including the satellite symposium held in conjunction with the conference). To obtain credit, pharmacists must attend a session in its entirety, participate in session-specific learning assessments, obtain a session-specific attendance code, complete a session evaluation, and record their participation online at https://amcplearn.org no later than 5:00 PM ET on Monday, April 29, 2019. No exceptions can be made after this date.
For additional information on AMCP’s continuing pharmacy education policies, please click here.
Statement of Commercial Support:
This program was developed by the Academy of Managed Care Pharmacy. The educational activities are supported by independent educational grants from Avexis Inc., Genzyme Corporation, Pfizer and Sarepta Therapeutics.
Meet the Moderator:
Clifford Goodman, PhD
Senior Vice President & Director
Lewin Center for Comparative Effectiveness Research
Falls Church, Virginia
Clifford Goodman is a senior vice president at The Lewin Group and has 30 years of experience in a wide range of health care areas, including health technology assessment; evidence-based health care; comparative effectiveness research; and studies pertaining to health care innovation. His recent work has also been wide ranging and includes such areas as oncology, cardiovascular disease, diabetes, blood disorders, HIV/AIDS, biosimilars, pharmacogenomics, personalized medicine, value frameworks, and value-based contracting. Clifford is an internationally recognized health policy issues moderator and facilitator of expert panels, health industry advisory boards, and workshops. He served as Chair of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC, 2009-12) for the US Centers for Medicare and Medicaid Services (CMS), as well as President of the professional society Health Technology Assessment international (HTAi, 2011-13). He is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).